Sign In
Buy LLY
$1,116.11
-5.06 (-0.451%)
At Close: Aug 04, 2026
Eli Lilly Shares Rise Premarket on Late-Stage Weight Loss Trial Success
05:35am, Monday, 08'th Jun 2026
A late-stage trial showed retatrutide was effective in weight loss and in alleviating obesity-linked conditions.
Top 50 High-Quality Dividend Growth Stocks For June 2026
04:51am, Monday, 08'th Jun 2026
I track a curated universe of 50 high-quality dividend growth stocks to identify attractive entry points based on valuation and forward return potential. Year-to-date, the universe lags SPY and SCHD,
In ATTAIN-1, women in perimenopause taking Foundayo lost up to 30.4 lbs (14.4%) and those in post-menopause lost up to 28.2 lbs (14.1%) In ATTAIN-2, women taking Foundayo lost significant weight
In TRIUMPH-1, participants on retatrutide 12 mg lost an average of 70.3 lbs (28.3%) over 80 weeks, with 65.3% achieving a BMI below 30, no longer meeting the BMI criteria for obesity In addition to we
Eli Lilly Leads Medical Stocks To Watch, While Google Finds Support
08:00am, Saturday, 06'th Jun 2026
Eli Lilly leads three health care stocks to watch as the market appears to be rotating into medicals. Google stock is finding key support too.
Dividend Champion, Contender, And Challenger Highlights: Week Of June 7
06:19pm, Friday, 05'th Jun 2026
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.
UnitedHealth, Eli Lilly Lead Healthcare Rebound as Investors Seek Stability
01:32pm, Friday, 05'th Jun 2026
UnitedHealth Group (UNH, Financials) and Eli Lilly (LLY, Financials) are emerging as leaders in a renewed healthcare sector rally as investors increasingly rota
Why Health Care's Seasonal Tailwind Looks Especially Compelling This Year
12:50pm, Friday, 05'th Jun 2026
The seasonal strength lines up with major medical and scientific conferences that cluster during this period.
LLY Rises 14% in a Month: Should You Hold as Obesity Growth Continues?
10:01am, Friday, 05'th Jun 2026
Eli Lilly stock gains 14% in a month as strong Q1 results, obesity drug coverage expansion and promising retatrutide data fueled momentum.
Healthcare ETFs: PJP Focuses on Pharmaceuticals, While XBI Zeroes in on Biotech
08:45am, Friday, 05'th Jun 2026
Compare risk profiles, dividend strategies, and portfolio concentration as these two healthcare ETFs take different paths to long-term returns.
Eli Lilly Cuts Planned Germany Investment Amid Policy Concerns
08:25am, Thursday, 04'th Jun 2026
Eli Lilly (LLY, Financials) plans to scale back its investment in Germany, reducing a previously announced â¬2.3 billion commitment by roughly half as concerns
Why Pfizer And Eli Lilly Are Betting On This $1.3 Billion AI Drug Discovery Startup
06:40am, Thursday, 04'th Jun 2026
L
Forget Weight Loss Drugs: Here Is Another Reason to Buy Eli Lilly Stock
03:00am, Thursday, 04'th Jun 2026
Eli Lilly has worked hard to diversify its pipeline. Three new acquisitions will further help decrease its exposure to its core market.
Move Over AI: Jeff Bezos and NVIDIA Are Quietly Backing a New Breakthrough Industry
12:22pm, Wednesday, 03'rd Jun 2026
Over recent months, a striking pattern has emerged: major capital allocators are positioning around AI-driven biology and longevity.
Where Will Eli Lilly Stock be In 2028?
12:09pm, Wednesday, 03'rd Jun 2026
Eli Lilly (NYSE:LLY | LLY Price Prediction) just grew revenue 55.5% in a single quarter while raising full-year guidance to $82 billion to $85 billion.
